Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 103

1.

Neuroblastoma cell lines contain pluripotent tumor initiating cells that are susceptible to a targeted oncolytic virus.

Mahller YY, Williams JP, Baird WH, Mitton B, Grossheim J, Saeki Y, Cancelas JA, Ratner N, Cripe TP.

PLoS One. 2009;4(1):e4235. doi: 10.1371/journal.pone.0004235. Epub 2009 Jan 21.

PMID:
19156211
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Detection of tumor stem cell markers in pancreatic carcinoma cell lines.

Olempska M, Eisenach PA, Ammerpohl O, Ungefroren H, Fandrich F, Kalthoff H.

Hepatobiliary Pancreat Dis Int. 2007 Feb;6(1):92-7.

PMID:
17287174
[PubMed - indexed for MEDLINE]
Free Article
3.

Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines.

Veselska R, Hermanova M, Loja T, Chlapek P, Zambo I, Vesely K, Zitterbart K, Sterba J.

BMC Cancer. 2008 Oct 16;8:300. doi: 10.1186/1471-2407-8-300.

PMID:
18925963
[PubMed - indexed for MEDLINE]
Free PMC Article
4.

CD133+ subpopulation of the HT1080 human fibrosarcoma cell line exhibits cancer stem-like characteristics.

Feng BH, Liu AG, Gu WG, Deng L, Cheng XG, Tong TJ, Zhang HZ.

Oncol Rep. 2013 Aug;30(2):815-23. doi: 10.3892/or.2013.2486. Epub 2013 May 23.

PMID:
23708735
[PubMed - indexed for MEDLINE]
5.

Resistance of stem-like cells from neuroblastoma cell lines to commonly used chemotherapeutic agents.

Vangipuram SD, Wang ZJ, Lyman WD.

Pediatr Blood Cancer. 2010 Mar;54(3):361-8. doi: 10.1002/pbc.22351.

PMID:
19927294
[PubMed - indexed for MEDLINE]
6.

Functional sphere profiling reveals the complexity of neuroblastoma tumor-initiating cell model.

Coulon A, Flahaut M, Mühlethaler-Mottet A, Meier R, Liberman J, Balmas-Bourloud K, Nardou K, Yan P, Tercier S, Joseph JM, Sommer L, Gross N.

Neoplasia. 2011 Oct;13(10):991-1004.

PMID:
22028624
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition.

Ying M, Wang S, Sang Y, Sun P, Lal B, Goodwin CR, Guerrero-Cazares H, Quinones-Hinojosa A, Laterra J, Xia S.

Oncogene. 2011 Aug 4;30(31):3454-67. doi: 10.1038/onc.2011.58. Epub 2011 Mar 7.

PMID:
21383690
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Partial biological characterization of cancer stem-like cell line (WJ(2)) of human glioblastoma multiforme.

Wang J, Wang X, Jiang S, Lin P, Zhang J, Wu Y, Xiong Z, Ren JJ, Yang H.

Cell Mol Neurobiol. 2008 Nov;28(7):991-1003. doi: 10.1007/s10571-008-9273-2. Epub 2008 Mar 19.

PMID:
18350379
[PubMed - indexed for MEDLINE]
9.

Analysis of stemness gene expression and CD133 abnormal methylation in neuroblastoma cell lines.

Schiapparelli P, Enguita-Germán M, Balbuena J, Rey JA, Lázcoz P, Castresana JS.

Oncol Rep. 2010 Nov;24(5):1355-62.

PMID:
20878131
[PubMed - indexed for MEDLINE]
10.

Expression of CD133 and other putative stem cell markers in uveal melanoma.

Thill M, Berna MJ, Grierson R, Reinhart I, Voelkel T, Piechaczek C, Galambos P, Jager MJ, Richard G, Lange C, Gehling UM.

Melanoma Res. 2011 Oct;21(5):405-16. doi: 10.1097/CMR.0b013e328348db10.

PMID:
21900792
[PubMed - indexed for MEDLINE]
11.

CD133 expression and identification of CD133/nestin positive cells in rhabdomyosarcomas and rhabdomyosarcoma cell lines.

Sana J, Zambo I, Skoda J, Neradil J, Chlapek P, Hermanova M, Mudry P, Vasikova A, Zitterbart K, Hampl A, Sterba J, Veselska R.

Anal Cell Pathol (Amst). 2011;34(6):303-18. doi: 10.3233/ACP-2011-0018.

PMID:
22156015
[PubMed - indexed for MEDLINE]
12.

Positive correlations of Oct-4 and Nanog in oral cancer stem-like cells and high-grade oral squamous cell carcinoma.

Chiou SH, Yu CC, Huang CY, Lin SC, Liu CJ, Tsai TH, Chou SH, Chien CS, Ku HH, Lo JF.

Clin Cancer Res. 2008 Jul 1;14(13):4085-95. doi: 10.1158/1078-0432.CCR-07-4404.

PMID:
18593985
[PubMed - indexed for MEDLINE]
Free Article
13.

The stem cell marker nestin predicts poor prognosis in human melanoma.

Piras F, Perra MT, Murtas D, Minerba L, Floris C, Maxia C, Demurtas P, Ugalde J, Ribatti D, Sirigu P.

Oncol Rep. 2010 Jan;23(1):17-24.

PMID:
19956860
[PubMed - indexed for MEDLINE]
14.

Virotherapy with a type 2 herpes simplex virus-derived oncolytic virus induces potent antitumor immunity against neuroblastoma.

Li H, Dutuor A, Tao L, Fu X, Zhang X.

Clin Cancer Res. 2007 Jan 1;13(1):316-22.

PMID:
17200370
[PubMed - indexed for MEDLINE]
Free Article
15.

Specific elimination of CD133+ tumor cells with targeted oncolytic measles virus.

Bach P, Abel T, Hoffmann C, Gal Z, Braun G, Voelker I, Ball CR, Johnston IC, Lauer UM, Herold-Mende C, Mühlebach MD, Glimm H, Buchholz CJ.

Cancer Res. 2013 Jan 15;73(2):865-74. doi: 10.1158/0008-5472.CAN-12-2221. Epub 2013 Jan 4.

PMID:
23293278
[PubMed - indexed for MEDLINE]
Free Article
16.

Positive correlation of Oct4 and ABCG2 to chemotherapeutic resistance in CD90(+)CD133(+) liver cancer stem cells.

Jia Q, Zhang X, Deng T, Gao J.

Cell Reprogram. 2013 Apr;15(2):143-50. doi: 10.1089/cell.2012.0048. Epub 2013 Feb 25.

PMID:
23438193
[PubMed - indexed for MEDLINE]
17.

Nestin and CD133: valuable stem cell-specific markers for determining clinical outcome of glioma patients.

Zhang M, Song T, Yang L, Chen R, Wu L, Yang Z, Fang J.

J Exp Clin Cancer Res. 2008 Dec 24;27:85. doi: 10.1186/1756-9966-27-85.

PMID:
19108713
[PubMed - indexed for MEDLINE]
Free PMC Article
18.

Targeting pediatric cancer stem cells with oncolytic virotherapy.

Friedman GK, Cassady KA, Beierle EA, Markert JM, Gillespie GY.

Pediatr Res. 2012 Apr;71(4 Pt 2):500-10. doi: 10.1038/pr.2011.58. Epub 2012 Feb 15. Review.

PMID:
22430386
[PubMed - indexed for MEDLINE]
Free PMC Article
19.

Cancer stem cells: lessons from melanoma.

La Porta C.

Stem Cell Rev. 2009 Mar;5(1):61-5. doi: 10.1007/s12015-008-9048-7. Epub 2008 Dec 18. Review.

PMID:
19093230
[PubMed - indexed for MEDLINE]
20.

CD133+ and nestin+ tumor-initiating cells dominate in N29 and N32 experimental gliomas.

Bexell D, Gunnarsson S, Siesjö P, Bengzon J, Darabi A.

Int J Cancer. 2009 Jul 1;125(1):15-22. doi: 10.1002/ijc.24306.

PMID:
19291792
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk